Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes Management
Blood Glucose Monitoring
FREESTYLE LIBRE ON SALE!!!!
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="tim2000s" data-source="post: 679541" data-attributes="member: 30007"><p>It really does look a lot like it's a case of your mileage may vary. I've been quietly impressed with the consistency between sensor and finger prick data and more importantly, the variance here is no different to the variance I've seen across different meter brands (+/- 1.5mmol/l across meters!!!!) which is slightly disturbing to say the least.</p><p></p><p>What I'm intrigued to find out is the variance across different users with different body fat levels. Mine's been effective at 13% body fat (which is relatively low compared to the general population). I wonder how differences might affect results.</p><p></p><p>What I'd also like to know is how many people actually have one of these and what the population with issues actually is. Given that I ordered mine a couple of weeks after they became available, and my order ID was GB5141, it suggests to me that there are >5,000 users in the UK, and if this is rolled out Europewide, we could expect that there are >60,000 users Europe wide. </p><p></p><p>If the people who have had issues are as limited as we are seeing, I would expect that Abbott would consider it to be a success. Looking at the number of users in the Facebook group, there are 948. Even if all of these are complaining, that would make up less than 2% of European users. Now this is all guesswork, but most manufacturers would take a 2% noise value on something new as being a reasonably low value. Especially on something as subjective as this. </p><p></p><p>What I have no data on is how the roll out of things like Dexcom and other CGMs worked and what the issues that people saw were. I'd be surprised if they were very different from this though, and I suspect the real issue here is that the platform is very low cost (relatively) and has had a much bigger public access roll out than other CGM products.</p></blockquote><p></p>
[QUOTE="tim2000s, post: 679541, member: 30007"] It really does look a lot like it's a case of your mileage may vary. I've been quietly impressed with the consistency between sensor and finger prick data and more importantly, the variance here is no different to the variance I've seen across different meter brands (+/- 1.5mmol/l across meters!!!!) which is slightly disturbing to say the least. What I'm intrigued to find out is the variance across different users with different body fat levels. Mine's been effective at 13% body fat (which is relatively low compared to the general population). I wonder how differences might affect results. What I'd also like to know is how many people actually have one of these and what the population with issues actually is. Given that I ordered mine a couple of weeks after they became available, and my order ID was GB5141, it suggests to me that there are >5,000 users in the UK, and if this is rolled out Europewide, we could expect that there are >60,000 users Europe wide. If the people who have had issues are as limited as we are seeing, I would expect that Abbott would consider it to be a success. Looking at the number of users in the Facebook group, there are 948. Even if all of these are complaining, that would make up less than 2% of European users. Now this is all guesswork, but most manufacturers would take a 2% noise value on something new as being a reasonably low value. Especially on something as subjective as this. What I have no data on is how the roll out of things like Dexcom and other CGMs worked and what the issues that people saw were. I'd be surprised if they were very different from this though, and I suspect the real issue here is that the platform is very low cost (relatively) and has had a much bigger public access roll out than other CGM products. [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Management
Blood Glucose Monitoring
FREESTYLE LIBRE ON SALE!!!!
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…